Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
South Korea · Delayed Price · Currency is KRW
10,470
+220 (2.15%)
At close: Apr 8, 2026
KRX:019170 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Apr '26 Apr 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
| 547,150 | 738,559 | 539,247 | 707,263 | 1,124,818 | 1,653,859 |
| 27.41% | 36.96% | -23.76% | -37.12% | -31.99% | -73.97% |
| 532,252 | 728,856 | 521,260 | 679,012 | 1,050,665 | 1,521,791 |
| 10470.00 | 14040.00 | 10310.00 | 13520.00 | 21150.00 | 31950.00 |
| 60.87 | 83.69 | - | - | - | - |
| 2.33 | 3.15 | 2.44 | 3.53 | 5.38 | 8.74 |
| 2.02 | 2.73 | 2.09 | 2.61 | 3.40 | 4.59 |
| 2.07 | 2.79 | 2.14 | 2.68 | 3.49 | 4.72 |
| 39.72 | 53.61 | - | - | - | - |
| 31.71 | 42.81 | - | - | - | - |
| 2.27 | 3.11 | 2.36 | 3.39 | 5.02 | 8.04 |
| 20.75 | 28.42 | - | - | - | - |
| 37.34 | 51.13 | - | - | - | - |
| 38.64 | 52.91 | - | - | - | - |
| 0.21 | 0.21 | 0.21 | 0.17 | 0.01 | 0.00 |
| 2.18 | 2.18 | - | - | - | - |
| 4.05 | 4.05 | - | - | - | - |
| -0.06 | -0.06 | -0.01 | -0.05 | -0.16 | -0.25 |
| -0.61 | -0.61 | 0.37 | 0.41 | 2.55 | 56.11 |
| -1.14 | -1.14 | 0.09 | 0.36 | 1.70 | 1.21 |
| 0.68 | 0.68 | 0.64 | 0.56 | 0.55 | 0.43 |
| 2.32 | 2.32 | 2.55 | 2.38 | 2.78 | 2.31 |
| 2.17 | 2.17 | 1.70 | 1.86 | 5.39 | 6.39 |
| 3.09 | 3.09 | 2.50 | 2.60 | 7.24 | 8.16 |
| 3.17% | 3.17% | -5.81% | -19.04% | -10.22% | -3.11% |
| 2.57% | 2.57% | -3.08% | -8.33% | -5.60% | -2.01% |
Return on Invested Capital (ROIC) | 5.56% | 5.54% | -6.64% | -17.78% | -12.47% | -6.22% |
Return on Capital Employed (ROCE) | 5.00% | 5.00% | -6.40% | -17.30% | -10.20% | -3.90% |
| 1.61% | 1.20% | -2.85% | -8.11% | -3.15% | -0.70% |
| 2.52% | 1.86% | -3.84% | -5.61% | -2.82% | -4.56% |
| -0.37% | -0.37% | 0.28% | - | - | -1.85% |
| -0.37% | -0.37% | 0.28% | - | - | -1.85% |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.